Novartis Shakes Up Leaders, Looks To Emerging Markets To Grow OTC Sales
This article was originally published in The Tan Sheet
Executive Summary
As part of the second major management shake-up in a year, Novartis is combining leadership roles for its consumer health division and veterinary medicines business under George Gunn, currently head of its animal health business
You may also be interested in...
Novartis Makes Room For OTC Division Head On Executive Committee
Novartis gives its OTC unit a direct line to the chief executive in an organizational realignment designed to strengthen and streamline the consumer businesses.
Novartis CEO Jimenez Highlights OTC Switches, Consumer Acquisitions
Incoming Novartis CEO Joe Jimenez plans to expand the Swiss firm's consumer health division over the next few years after he takes the reins from his predecessor Daniel Vasella
Ebeling Returns As Novartis Consumer Health CEO
Novartis is swapping its Consumer Health and Pharmaceutical division heads as part of an initiative intended to accelerate growth in its non-pharmaceutical businesses, the firm announced Oct. 18